{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:57:12Z","timestamp":1781078232811,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"DOI":"10.1007\/s11926-026-01216-0","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T08:23:55Z","timestamp":1774081435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is Gout an Autoinflammatory Disease?"],"prefix":"10.1007","volume":"28","author":[{"given":"Naomi","family":"Schlesinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,21]]},"reference":[{"issue":"5","key":"1216_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jare.2017.04.008","volume":"8","author":"G Ragab","year":"2017","unstructured":"Ragab G, Elshahaly M, Bardin T. Gout: An old disease in new perspective - A review. J Adv Res. 2017;8(5):495\u2013511.","journal-title":"J Adv Res"},{"issue":"1","key":"1216_CR2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41392-024-01916-y","volume":"9","author":"L Du","year":"2024","unstructured":"Du L, et al. Hyperuricemia and its related diseases: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024;9(1):212.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"1216_CR3","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.semarthrit.2020.06.015","volume":"50","author":"S Bodofsky","year":"2020","unstructured":"Bodofsky S, et al. Advances in our understanding of gout as an auto-inflammatory disease. Semin Arthritis Rheum. 2020;50(5):1089\u2013100.","journal-title":"Semin Arthritis Rheum"},{"issue":"7081","key":"1216_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440(7081):237\u201341.","journal-title":"Nature"},{"key":"1216_CR5","first-page":"102421","volume":"109","author":"J Krainer","year":"2020","unstructured":"Krainer J, Siebenhandl S, Weinhausel A. Systemic autoinflammatory Dis J Autoimmun. 2020;109:102421.","journal-title":"Systemic autoinflammatory Dis J Autoimmun"},{"issue":"2","key":"1216_CR6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002;10(2):417\u201326.","journal-title":"Mol Cell"},{"issue":"11","key":"1216_CR7","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.cell.2023.04.025","volume":"186","author":"KC Barnett","year":"2023","unstructured":"Barnett KC, et al. A 360 degrees view of the inflammasome: Mechanisms of activation, cell death, and diseases. Cell. 2023;186(11):2288\u2013312.","journal-title":"Cell"},{"key":"1216_CR8","doi-asserted-by":"publisher","first-page":"1744393","DOI":"10.3389\/fimmu.2025.1744393","volume":"16","author":"S Umar","year":"2025","unstructured":"Umar S, et al. Modulation of IRAK4 as a therapeutic strategy against monosodium urate- and xanthine-induced inflammation in macrophages and HepG2 cells. Front Immunol. 2025;16:1744393.","journal-title":"Front Immunol"},{"issue":"1","key":"1216_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1074\/jbc.M110.139048","volume":"286","author":"C Schorn","year":"2011","unstructured":"Schorn C, et al. Sodium overload and water influx activate the NALP3 inflammasome. J Biol Chem. 2011;286(1):35\u201341.","journal-title":"J Biol Chem"},{"issue":"11","key":"1216_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","volume":"13","author":"AK So","year":"2017","unstructured":"So AK, Martinon F. Inflammation in gout: mechanisms and therapeutic targets. Nat Rev Rheumatol. 2017;13(11):639\u201347.","journal-title":"Nat Rev Rheumatol"},{"key":"1216_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fcell.2020.00167","volume":"8","author":"A Chevriaux","year":"2020","unstructured":"Chevriaux A, et al. Cathepsin B Is Required for NLRP3 Inflammasome Activation in Macrophages, Through NLRP3 Interaction. Front Cell Dev Biol. 2020;8:167.","journal-title":"Front Cell Dev Biol"},{"key":"1216_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","volume":"27","author":"F Martinon","year":"2009","unstructured":"Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol. 2009;27:229\u201365.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"1216_CR13","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/annrheumdis-2015-208767","volume":"75","author":"A Abhishek","year":"2016","unstructured":"Abhishek A, Valdes AM, Doherty M. Low omega-3 fatty acid levels associate with frequent gout attacks: a case control study. Ann Rheum Dis. 2016;75(4):784\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1216_CR14","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/annrheumdis-2013-203803","volume":"74","author":"A Scanu","year":"2015","unstructured":"Scanu A, et al. High-density lipoproteins inhibit urate crystal-induced inflammation in mice. Ann Rheum Dis. 2015;74(3):587\u201394.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1216_CR15","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1080\/15257770802257952","volume":"27","author":"C Gersch","year":"2008","unstructured":"Gersch C, et al. Inactivation of nitric oxide by uric acid. Nucleosides Nucleotides Nucleic Acids. 2008;27(8):967\u201378.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"32","key":"1216_CR16","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.2174\/138161205774913255","volume":"11","author":"GK Glantzounis","year":"2005","unstructured":"Glantzounis GK, et al. Uric acid and oxidative stress. Curr Pharm Des. 2005;11(32):4145\u201351.","journal-title":"Curr Pharm Des"},{"issue":"2","key":"1216_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41584-019-0334-3","volume":"16","author":"LAB Joosten","year":"2020","unstructured":"Joosten LAB, et al. Asymptomatic hyperuricaemia: a silent activator of the innate immune system. Nat Rev Rheumatol. 2020;16(2):75\u201386.","journal-title":"Nat Rev Rheumatol"},{"issue":"48","key":"1216_CR18","doi-asserted-by":"publisher","first-page":"40732","DOI":"10.1074\/jbc.M112.399899","volume":"287","author":"MA Lanaspa","year":"2012","unstructured":"Lanaspa MA, et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem. 2012;287(48):40732\u201344.","journal-title":"J Biol Chem"},{"issue":"2","key":"1216_CR19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.freeradbiomed.2010.04.010","volume":"49","author":"W Imaram","year":"2010","unstructured":"Imaram W, et al. Radicals in the reaction between peroxynitrite and uric acid identified by electron spin resonance spectroscopy and liquid chromatography mass spectrometry. Free Radic Biol Med. 2010;49(2):275\u201381.","journal-title":"Free Radic Biol Med"},{"key":"1216_CR20","doi-asserted-by":"publisher","first-page":"39884","DOI":"10.1038\/srep39884","volume":"7","author":"TT Braga","year":"2017","unstructured":"Braga TT, et al. Soluble Uric Acid Activates the NLRP3 Inflammasome. Sci Rep. 2017;7:39884.","journal-title":"Sci Rep"},{"key":"1216_CR21","doi-asserted-by":"crossref","unstructured":"Li J et al. Engineering macrophage via biomaterial-mediated mitochondrial regulation: mechanisms and strategies. Research. 2025;8:0883.","DOI":"10.34133\/research.0883"},{"key":"1216_CR22","doi-asserted-by":"publisher","first-page":"1512093","DOI":"10.3389\/fimmu.2025.1512093","volume":"16","author":"W Gu","year":"2025","unstructured":"Gu W, Zhao J, Xu Y. Hyperuricemia-induced complications: dysfunctional macrophages serve as a potential bridge. Front Immunol. 2025;16:1512093.","journal-title":"Front Immunol"},{"key":"1216_CR23","doi-asserted-by":"publisher","first-page":"213005","DOI":"10.1016\/j.bioadv.2022.213005","volume":"139","author":"C Chen","year":"2022","unstructured":"Chen C, et al. Monosodium urate crystals with controlled shape and aspect ratio for elucidating the pathological progress of acute gout. Biomater Adv. 2022;139:213005.","journal-title":"Biomater Adv"},{"issue":"9","key":"1216_CR24","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.molmed.2024.05.010","volume":"30","author":"Q Ma","year":"2024","unstructured":"Ma Q, Steiger S. Neutrophils and extracellular traps in crystal-associated diseases. Trends Mol Med. 2024;30(9):809\u201323.","journal-title":"Trends Mol Med"},{"issue":"11","key":"1216_CR25","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1038\/s41588-024-01921-5","volume":"56","author":"TJ Major","year":"2024","unstructured":"Major TJ, et al. A genome-wide association analysis reveals new pathogenic pathways in gout. Nat Genet. 2024;56(11):2392\u2013406.","journal-title":"Nat Genet"},{"key":"1216_CR26","doi-asserted-by":"publisher","first-page":"1759720X2513663","DOI":"10.1177\/1759720X251366360","volume":"17","author":"TR Merriman","year":"2025","unstructured":"Merriman TR, Rosas-Chavez F, Stamp LK. The genetics of gout: translation into clinical practice. Ther Adv Musculoskelet Dis. 2025;17:1759720X251366360.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"1216_CR27","doi-asserted-by":"publisher","first-page":"5611","DOI":"10.2147\/JIR.S378341","volume":"15","author":"H Zhang","year":"2022","unstructured":"Zhang H, et al. Role of NINJ1 in Gout Flare and Potential as a Drug Target. J Inflamm Res. 2022;15:5611\u201320.","journal-title":"J Inflamm Res"},{"issue":"10","key":"1216_CR28","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1182\/blood.2022015384","volume":"140","author":"M Agrawal","year":"2022","unstructured":"Agrawal M, et al. TET2-mutant clonal hematopoiesis and risk of gout. Blood. 2022;140(10):1094\u2013103.","journal-title":"Blood"},{"issue":"4","key":"1216_CR29","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.immuni.2025.02.023","volume":"58","author":"I Cobo","year":"2025","unstructured":"Cobo I, et al. Particle uptake by macrophages triggers bifurcated transcriptional pathways that differentially regulate inflammation and lysosomal gene expression. Immunity. 2025;58(4):826\u2013e8428.","journal-title":"Immunity"},{"issue":"1","key":"1216_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/art.42969","volume":"77","author":"A Ji","year":"2025","unstructured":"Ji A, et al. Novel Genetic Loci in Early-Onset Gout Derived From Whole-Genome Sequencing of an Adolescent Gout Cohort. Arthritis Rheumatol. 2025;77(1):107\u201315.","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"1216_CR31","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3349\/ymj.2020.61.6.533","volume":"61","author":"SK Kim","year":"2020","unstructured":"Kim SK, Choe JY, Park KY. Ethanol Augments Monosodium Urate-Induced NLRP3 Inflammasome Activation via Regulation of AhR and TXNIP in Human Macrophages. Yonsei Med J. 2020;61(6):533\u201341.","journal-title":"Yonsei Med J"},{"issue":"1","key":"1216_CR32","first-page":"5","volume":"30","author":"HJ Edenberg","year":"2007","unstructured":"Edenberg HJ. The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Res Health. 2007;30(1):5\u201313.","journal-title":"Alcohol Res Health"},{"issue":"9","key":"1216_CR33","doi-asserted-by":"publisher","first-page":"e70421","DOI":"10.1111\/1756-185x.70421","volume":"28","author":"MC Martinez-Avila","year":"2025","unstructured":"Martinez-Avila MC, et al. Exploring the Relationship Between Alcohol Consumption and Gout: A Narrative Review. Int J Rheum Dis. 2025;28(9):e70421.","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"1216_CR34","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s11926-013-0398-z","volume":"16","author":"N Schlesinger","year":"2014","unstructured":"Schlesinger N. Anti-interleukin-1 therapy in the management of gout. Curr Rheumatol Rep. 2014;16(2):398.","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"1216_CR35","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1186\/ar3297","volume":"13","author":"N Schlesinger","year":"2011","unstructured":"Schlesinger N, et al. Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study. Arthritis Res Ther. 2011;13(2):R53.","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"1216_CR36","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1002\/art.41699","volume":"73","author":"KG Saag","year":"2021","unstructured":"Saag KG, et al. A Randomized, Phase II Study Evaluating the Efficacy and Safety of Anakinra in the Treatment of Gout Flares. Arthritis Rheumatol. 2021;73(8):1533\u201342.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"1216_CR37","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13075-023-03098-4","volume":"25","author":"N Schlesinger","year":"2023","unstructured":"Schlesinger N, et al. Interleukin-1beta inhibitors for the management of acute gout flares: a systematic literature review. Arthritis Res Ther. 2023;25(1):128.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"1216_CR38","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S2665-9913(20)30065-5","volume":"2","author":"V Kluck","year":"2020","unstructured":"Kluck V, et al. Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial. Lancet Rheumatol. 2020;2(5):e270\u201380.","journal-title":"Lancet Rheumatol"},{"issue":"3","key":"1216_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11926-023-01128-3","volume":"26","author":"K Yip","year":"2024","unstructured":"Yip K, et al. Pipeline Therapies for Gout. Curr Rheumatol Rep. 2024;26(3):69\u201380.","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"1216_CR40","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s10787-020-00758-8","volume":"28","author":"CY Qiao","year":"2020","unstructured":"Qiao CY, et al. Management of Gout-associated MSU crystals-induced NLRP3 inflammasome activation by procyanidin B2: targeting IL-1beta and Cathepsin B in macrophages. Inflammopharmacology. 2020;28(6):1481\u201393.","journal-title":"Inflammopharmacology"},{"issue":"7","key":"1216_CR41","first-page":"1293","volume":"40","author":"N Schlesinger","year":"2022","unstructured":"Schlesinger N, et al. Components of tart cherry juice inhibit NFkappaB activation and inflammation in acute gout. Clin Exp Rheumatol. 2022;40(7):1293\u20138.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"1216_CR42","doi-asserted-by":"publisher","first-page":"6239","DOI":"10.1038\/s41598-022-09970-8","volume":"12","author":"WH El-Maadawy","year":"2022","unstructured":"El-Maadawy WH, et al. Co-treatment with Esculin and erythropoietin protects against renal ischemia-reperfusion injury via P2X7 receptor inhibition and PI3K\/Akt activation. Sci Rep. 2022;12(1):6239.","journal-title":"Sci Rep"},{"issue":"3","key":"1216_CR43","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.semarthrit.2019.11.009","volume":"50","author":"N Schlesinger","year":"2020","unstructured":"Schlesinger N, Brunetti L. Beyond urate lowering: Analgesic and anti-inflammatory properties of allopurinol. Semin Arthritis Rheum. 2020;50(3):444\u201350.","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"1216_CR44","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/ni.2550","volume":"14","author":"T Misawa","year":"2013","unstructured":"Misawa T, et al. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat Immunol. 2013;14(5):454\u201360.","journal-title":"Nat Immunol"},{"key":"1216_CR45","doi-asserted-by":"crossref","unstructured":"Wolowiec L et al. Colchicine in contemporary pharmacotherapy: mechanistic insights and clinical horizons. J Clin Med. 2025;14(19):7078.","DOI":"10.3390\/jcm14197078"}],"updated-by":[{"DOI":"10.1007\/s11926-026-01226-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000}}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-026-01216-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-026-01216-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-026-01216-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:02:49Z","timestamp":1781074969000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-026-01216-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1216"],"URL":"https:\/\/doi.org\/10.1007\/s11926-026-01216-0","relation":{},"ISSN":["1534-6307"],"issn-type":[{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,21]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this article was updated to include revisions to Figure 2 and its legend.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11926-026-01226-y","URL":"https:\/\/doi.org\/10.1007\/s11926-026-01226-y","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"Conflict of interest: NS has served as an advisor or review panel member for Olatec, AMGEN, Protalix, Sobi, Shanton, Arthrosi, Scilex, Eli Lilly, and Avalo Therapeutics.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}